Company: VMCWF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001827
Chunk: 329

Company: Valuence Merger Corp. I
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 329
---
 upon the occurrence of future events.
The warrants are exercisable to purchase 17,939,643 Class A ordinary shares in the aggregate. As of December 31, 2024 and 2023, the Company
did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then
share in the earnings of the Company. As a result, diluted net income per ordinary share is the same as basic net income per ordinary
share for the periods presented.

    F-14

The
following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):

 SCHEDULE OF NET LOSS PER COMMON SHARE 

     Class A  
     Class B  
     Class A  
     Class B 

    For the Year Ended December 31, 

    2024  
    2023 

     Class
                                                                                                 A redeemable  
     Class
                                            A and Class B non-redeemable  
     Class
                                            A redeemable  
     Class
                                            A and Class B non-redeemable 
  
    Basic and diluted net income per ordinary share 

    Numerator: 

    Allocation of net income, as adjusted 
    $969,121  
    $1,434,008  
    $3,339,582  
    $1,431,889 
  
    Denominator: 

    Basic and diluted weighted average shares outstanding 
     3,718,651  
     5,502,490  
     12,833,415  
     5,502,490 
  
    Basic and diluted net income per ordinary share 
    $0.26  
    $0.26  
    $0.26  
    $0.26 

Concentration
of Credit Risk

Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack
of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and
cash flows.

Fair
Value of Financial Instruments

The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “